Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma.
J Urol. 1999 Jan;161(1):357-8.
No abstract available.
[MEDLINE record in process]
PMID: 10037437; UI: 99155041.
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
J Urol. 1999 Jan;161(1):350-1.
No abstract available.
[MEDLINE record in process]
PMID: 10037436; UI: 99155040.
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
J Urol. 1999 Jan;161(1):332-7.
[MEDLINE record in process]
PMID: 10037433; UI: 99155037.
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.
J Urol. 1999 Jan;161(1):304-8.
[MEDLINE record in process]
PMID: 10037428; UI: 99155032.
Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor.
J Urol. 1999 Jan;161(1):290-7.
[MEDLINE record in process]
PMID: 10037426; UI: 99155030.
Re: Editorial comment on clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies.
J Urol. 1999 Jan;161(1):231.
No abstract available.
[MEDLINE record in process]
PMID: 10037410; UI: 99155014.
Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy.
J Urol. 1999 Jan;161(1):188-92.
[MEDLINE record in process]
PMID: 10037395; UI: 99154999.
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
J Urol. 1999 Jan;161(1):182-7.
[MEDLINE record in process]
PMID: 10037394; UI: 99154998.
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer.
J Urol. 1999 Jan;161(1):176-81.
[MEDLINE record in process]
PMID: 10037393; UI: 99154997.
Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer.
J Urol. 1999 Jan;161(1):173-5.
[MEDLINE record in process]
PMID: 10037392; UI: 99154996.
A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma.
J Urol. 1999 Jan;161(1):169-72.
[MEDLINE record in process]
PMID: 10037391; UI: 99154995.
Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
J Urol. 1999 Jan;161(1):156-62.
[MEDLINE record in process]
PMID: 10037389; UI: 99154993.
Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants.
J Urol. 1999 Jan;161(1):152-5.
[MEDLINE record in process]
PMID: 10037388; UI: 99154992.
A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
J Urol. 1999 Jan;161(1):144-51.
[MEDLINE record in process]
PMID: 10037387; UI: 99154991.
Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
J Urol. 1999 Jan;161(1):139-43.
[MEDLINE record in process]
PMID: 10037386; UI: 99154990.
Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
J Urol. 1999 Jan;161(1):133-8.
[MEDLINE record in process]
PMID: 10037385; UI: 99154989.
Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
J Urol. 1999 Jan;161(1):128-32.
[MEDLINE record in process]
PMID: 10037384; UI: 99154988.
Distribution of post-void residual urine volume in randomly selected men.
J Urol. 1999 Jan;161(1):122-7.
[MEDLINE record in process]
PMID: 10037383; UI: 99154987.
Measurement of thermal effects on the optical properties of prostate tissue at wavelenghts of 1,064 and 633 nm.
Lasers Surg Med. 1999;24(1):38-47.
[MEDLINE record in process]
PMID: 10037350; UI: 99154954.
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer.
J Natl Cancer Inst. 1999 Feb 3;91(3):244-51.
[MEDLINE record in process]
PMID: 10037102; UI: 99154706.
PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer.
Radiat Oncol Investig. 1999;7(1):30-5.
[MEDLINE record in process]
PMID: 10030621; UI: 99153692.
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):447-54.
[MEDLINE record in process]
PMID: 10030274; UI: 99153345.
Computerized design of target margins for treatment uncertainties in conformal radiotherapy.
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):437-45.
[MEDLINE record in process]
PMID: 10030273; UI: 99153344.
Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):385-91.
[MEDLINE record in process]
PMID: 10030266; UI: 99153337.
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation.
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):379-83.
[MEDLINE record in process]
PMID: 10030265; UI: 99153336.
Comparability of CT-based and TRUS-based prostate volumes.
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):375-8.
[MEDLINE record in process]
PMID: 10030264; UI: 99153335.
Evaluation of prostate specific antigen in the prognosis of patients with advanced prostate cancer.
Rev Paul Med. 1998 Sep-Oct;116(5):1798-802.
[MEDLINE record in process]
PMID: 10030104; UI: 99154372.
Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
Hum Pathol. 1999 Feb;30(2):168-72.
[MEDLINE record in process]
PMID: 10029444; UI: 99151902.
Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
Cancer Res. 1999 Feb 15;59(4):872-9.
[MEDLINE record in process]
PMID: 10029078; UI: 99151536.
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.
Cancer Res. 1999 Feb 15;59(4):823-5.
[MEDLINE record in process]
PMID: 10029070; UI: 99151528.
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
Cancer Res. 1999 Feb 15;59(4):803-6.
[MEDLINE record in process]
PMID: 10029066; UI: 99151524.
A fluorescent orthotopic bone metastasis model of human prostate cancer.
Cancer Res. 1999 Feb 15;59(4):781-6.
[MEDLINE record in process]
PMID: 10029062; UI: 99151520.
[Prostatic cancer with cystic formation: a case report].
Hinyokika Kiyo. 1998 Dec;44(12):883-6. Japanese.
[MEDLINE record in process]
PMID: 10028435; UI: 99152789.
Semiquantitative evaluation of alpha1A-adrenoceptor subtype mRNA in human hypertrophied and non-hypertrophied prostates: regional comparison.
Life Sci. 1999;64(3):201-10.
[MEDLINE record in process]
PMID: 10027751; UI: 99150100.
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.
Am J Pathol. 1999 Feb;154(2):543-51.
[MEDLINE record in process]
PMID: 10027412; UI: 99149658.
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.
Am J Pathol. 1999 Feb;154(2):313-23.
[MEDLINE record in process]
PMID: 10027389; UI: 99149635.
Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer.
Br J Cancer. 1999 Feb;79(3-4):551-7.
[MEDLINE record in process]
PMID: 10027329; UI: 99149575.
Evaluation and management of the man who has failed primary curative therapy for prostate cancer.
Urol Clin North Am. 1998 Nov;25(4):591-601.
[MEDLINE record in process]
PMID: 10026768; UI: 99150830.
Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination, and transrectal ultrasound and prostate biopsy.
Urol Clin North Am. 1998 Nov;25(4):581-9, viii.
[MEDLINE record in process]
PMID: 10026767; UI: 99150829.
The medical management of lower urinary tract symptoms and benign prostatic hyperplasia.
Urol Clin North Am. 1998 Nov;25(4):555-69, vii.
[MEDLINE record in process]
PMID: 10026765; UI: 99150827.
Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.
Cancer Lett. 1998 Dec 25;134(2):177-80.
[MEDLINE record in process]
PMID: 10025878; UI: 99148745.
Using vascular structure for CT-SPECT registration in the pelvis.
J Nucl Med. 1999 Feb;40(2):347-51.
[MEDLINE record in process]
PMID: 10025845; UI: 99148712.
cDNA, genomic cloning, and gene expression analysis of mouse PSP94.
DNA Cell Biol. 1999 Jan;18(1):11-26.
[MEDLINE record in process]
PMID: 10025505; UI: 99148372.
Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer.
Int J Oncol. 1999 Mar;14(3):535-541.
[Record as supplied by publisher]
PMID: 10024688.
Differential expression of stathmin during neoplastic conversion of human prostate epithelial cells is reversed by hypomethylating agent, 5-azacytidine.
Int J Oncol. 1999 Mar;14(3):529-534.
[Record as supplied by publisher]
PMID: 10024687.
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
Int J Oncol. 1999 Mar;14(3):501-508.
[Record as supplied by publisher]
PMID: 10024683.
Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer.
Int J Oncol. 1999 Mar;14(3):495-500.
[Record as supplied by publisher]
PMID: 10024682.
Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
Protein Expr Purif. 1999 Feb;15(1):62-8.
[MEDLINE record in process]
PMID: 10024471; UI: 99150483.
Monitoring the health status and impact of treatment on Americans: the Medicare Beneficiary Health Status Registry.
Med Care. 1999 Feb;37(2):189-203.
[MEDLINE record in process]
PMID: 10024123; UI: 99146728.
Should African-American men be tested for prostate carcinoma at an earlier age than white men?
Cancer. 1999 Jan 15;85(2):472-7.
[MEDLINE record in process]
PMID: 10023717; UI: 99146322.
Structure and expression of variant BRCA2a lacking the transactivation domain.
Oncol Rep. 1999 Mar;6(2):437-440.
[Record as supplied by publisher]
PMID: 10023017.
Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line.
Cell Tissue Res. 1999 Feb 17;295(3):505-512.
[Record as supplied by publisher]
PMID: 10022970.
Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
Oncogene. 1999 Feb 11;18(6):1313-24.
[MEDLINE record in process]
PMID: 10022813; UI: 99145411.
Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
J Urol. 1999 Mar;161(3):960-3.
[MEDLINE record in process]
PMID: 10022734; UI: 99145332.
Re: The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.
J Urol. 1999 Mar;161(3):924-6.
No abstract available.
[MEDLINE record in process]
PMID: 10022723; UI: 99145321.
Neurourological insights into the etiology of genitourinary pain in men.
J Urol. 1999 Mar;161(3):903-8.
[MEDLINE record in process]
PMID: 10022711; UI: 99145309.
Long-term survival after radiotherapy alone: radiation therapy oncology group prostate cancer trials.
J Urol. 1999 Mar;161(3):864-8.
[MEDLINE record in process]
PMID: 10022702; UI: 99145300.
Prostate specific antigen doubling time after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.
J Urol. 1999 Mar;161(3):847-52.
[MEDLINE record in process]
PMID: 10022699; UI: 99145297.
Vesicourethral reconstruction in radical retropubic prostatectomy: an alternative technique.
J Urol. 1999 Mar;161(3):844-6.
[MEDLINE record in process]
PMID: 10022698; UI: 99145296.
Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.
J Urol. 1999 Mar;161(3):835-9.
[MEDLINE record in process]
PMID: 10022696; UI: 99145294.
Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
J Urol. 1999 Mar;161(3):831-4.
[MEDLINE record in process]
PMID: 10022695; UI: 99145293.
Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells.
J Cell Biochem. 1999 Mar 15;72(4):458-69.
[MEDLINE record in process]
PMID: 10022606; UI: 99145204.
180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18.
J Cell Biochem. 1999 Mar 1;72(3):356-67.
[MEDLINE record in process]
PMID: 10022517; UI: 99145115.
Characterization of the human 36-kDa carboxyl terminal LIM domain protein.
J Cell Biochem. 1999 Feb 1;72(2):279-85.
[MEDLINE record in process]
PMID: 10022510; UI: 99145108.
Tiered screening and testing strategy for xenoestrogens and antiandrogens.
Toxicol Lett. 1998 Dec 28;102-103:677-80.
[MEDLINE record in process]
PMID: 10022334; UI: 99144932.
Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesis.
Toxicol Lett. 1998 Dec 28;102-103:441-6.
[MEDLINE record in process]
PMID: 10022293; UI: 99144891.
Dietary phytoestrogens and their role in hormonally dependent disease.
Toxicol Lett. 1998 Dec 28;102-103:349-54.
[MEDLINE record in process]
PMID: 10022277; UI: 99144875.
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model.
Methods Find Exp Clin Pharmacol. 1998 Nov;20(9):739-42.
[MEDLINE record in process]
PMID: 10022026; UI: 99146052.
Fine needle aspiration cytology of small cell neuroendocrine carcinoma of the breast. A case report.
Acta Cytol. 1997 Jul-Aug;41(4 Suppl):1341-4.
[MEDLINE record in process]
PMID: 9990271; UI: 99144082.
[A clinical study of decreased bone density in the patients treated with long term luteinizing hormone releasing hormone analogue (LHRH-a)--The risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate].
Nippon Hinyokika Gakkai Zasshi. 1998 Dec;89(12):961-6. Japanese.
[MEDLINE record in process]
PMID: 9990228; UI: 99144039.
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8.
[MEDLINE record in process]
PMID: 9990064; UI: 99145590.
Needle biopsies of prostate cancer.
Am J Surg Pathol. 1999 Feb;23(2):239-40.
No abstract available.
[MEDLINE record in process]
PMID: 9989854; UI: 99142960.
Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
Am J Surg Pathol. 1999 Feb;23(2):147-52.
[MEDLINE record in process]
PMID: 9989840; UI: 99142946.
Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202.
Oncogene. 1999 Jan 21;18(3):807-11.
[MEDLINE record in process]
PMID: 9989832; UI: 99142938.
Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
Oncogene. 1999 Jan 21;18(3):623-31.
[MEDLINE record in process]
PMID: 9989812; UI: 99142918.
Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry.
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):217-25.
[MEDLINE record in process]
PMID: 9989529; UI: 99142635.
Prostate seed implant quality assessment using MR and CT image fusion.
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):67-72.
[MEDLINE record in process]
PMID: 9989515; UI: 99142621.
Definition of the prostate in CT and MRI: a multi-observer study.
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):57-66.
[MEDLINE record in process]
PMID: 9989514; UI: 99142620.
Pion conformal radiation of prostate cancer: results of a randomized study.
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):47-55.
[MEDLINE record in process]
PMID: 9989513; UI: 99142619.
Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Mt Sinai J Med. 1999 Jan;66(1):26-30.
[MEDLINE record in process]
PMID: 9989102; UI: 99143647.
Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members.
J Biol Chem. 1999 Feb 19;274(8):4570-6.
[MEDLINE record in process]
PMID: 9988691; UI: 99143111.
BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer.
Int J Cancer. 1999 Feb 19;84(1):19-23.
[MEDLINE record in process]
PMID: 9988226; UI: 99140725.
Association between diesel exposure at work and prostate cancer.
Scand J Work Environ Health. 1998 Dec;24(6):486-94.
[MEDLINE record in process]
PMID: 9988091; UI: 99140590.
Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP.
Histol Histopathol. 1999 Jan;14(1):125-34.
[MEDLINE record in process]
PMID: 9987657; UI: 99142130.
Antitumor benzothiazoles. 7. Synthesis Of 2-(4-Acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines.
J Med Chem. 1999 Feb 11;42(3):381-92.
[MEDLINE record in process]
PMID: 9986708; UI: 99143286.
Loss of heterozygosity of the TP53 tumor suppressor gene and detection of point mutations by the non-isotopic RNAse cleavage assay in prostate cancer.
Cancer Genet Cytogenet. 1999 Jan 1;108(1):42-7.
[MEDLINE record in process]
PMID: 9973923; UI: 99139503.
Brachytherapy in early prostate cancer--early experience.
J Ky Med Assoc. 1999 Jan;97(1):12-6.
[MEDLINE record in process]
PMID: 9973780; UI: 99139183.
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.
Cancer Res. 1999 Feb 1;59(3):684-8.
[MEDLINE record in process]
PMID: 9973218; UI: 99137503.
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Cancer Res. 1999 Feb 1;59(3):639-44.
[MEDLINE record in process]
PMID: 9973212; UI: 99137497.
Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid.
Cancer Res. 1999 Feb 1;59(3):521-4.
[MEDLINE record in process]
PMID: 9973192; UI: 99137477.
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease.
Prostate. 1999 Jan 1;38(1):73-8.
[MEDLINE record in process]
PMID: 9973112; UI: 99137397.
Impaired expression and posttranslational processing of connexin43 and downregulation of gap junctional communication in neoplastic human prostate cells.
Prostate. 1999 Jan 1;38(1):55-9.
[MEDLINE record in process]
PMID: 9973110; UI: 99137395.
Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2.
Prostate. 1999 Jan 1;38(1):46-54.
[MEDLINE record in process]
PMID: 9973109; UI: 99137394.
Overexpression of cyclin D1 is rare in human prostate carcinoma.
Prostate. 1999 Jan 1;38(1):40-5.
[MEDLINE record in process]
PMID: 9973108; UI: 99137393.
Identification of dipeptidyl peptidase IV as the antigen of a monoclonal anti-prostasome antibody.
Prostate. 1999 Jan 1;38(1):35-9.
[MEDLINE record in process]
PMID: 9973107; UI: 99137392.
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) grade.
Prostate. 1999 Jan 1;38(1):28-34.
[MEDLINE record in process]
PMID: 9973106; UI: 99137391.
Effects of mepartricin, a polyene macrolide agent, on fecal excretion and serum concentration of estrogen and number of prostatic estrogen receptors in immature rats.
Prostate. 1999 Jan 1;38(1):17-27.
[MEDLINE record in process]
PMID: 9973105; UI: 99137390.
Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry.
Prostate. 1999 Jan 1;38(1):1-16.
[MEDLINE record in process]
PMID: 9973104; UI: 99137389.
Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group.
Prostate. 1999 Feb 1;38(2):166-71.
No abstract available.
[MEDLINE record in process]
PMID: 9973103; UI: 99137388.
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
Prostate. 1999 Feb 1;38(2):151-8.
[MEDLINE record in process]
PMID: 9973101; UI: 99137386.
Differences in prostate size between patients from University and Veterans Affairs Medical Center populations.
Prostate. 1999 Feb 1;38(2):144-50.
[MEDLINE record in process]
PMID: 9973100; UI: 99137385.
Determination of optimal freezing parameters of human prostate cancer in a nude mouse model.
Prostate. 1999 Feb 1;38(2):137-43.
[MEDLINE record in process]
PMID: 9973099; UI: 99137384.
Involvement of heparin affin regulatory peptide in human prostate cancer.
Prostate. 1999 Feb 1;38(2):126-36.
[MEDLINE record in process]
PMID: 9973098; UI: 99137383.
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis.
Prostate. 1999 Feb 1;38(2):118-25.
[MEDLINE record in process]
PMID: 9973097; UI: 99137382.
Differential growth rates in stromal cultures of human prostate derived from patients of varying ages.
Prostate. 1999 Feb 1;38(2):110-7.
[MEDLINE record in process]
PMID: 9973096; UI: 99137381.
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.
Prostate. 1999 Feb 1;38(2):100-9.
[MEDLINE record in process]
PMID: 9973095; UI: 99137380.
Numerical chromosomal anomalies in latent adenocarcinomas of the prostate.
Prostate. 1999 Feb 1;38(2):92-9.
[MEDLINE record in process]
PMID: 9973094; UI: 99137379.
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.
Prostate. 1999 Feb 1;38(2):83-91.
[MEDLINE record in process]
PMID: 9973093; UI: 99137378.
Ultrastructure and lectin cytochemistry of the cloacal pelvic glands in the male newt Triturus marmoratus marmoratus.
Anat Rec. 1999 Feb 1;254(2):196-204.
[MEDLINE record in process]
PMID: 9972804; UI: 99137089.
4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
Int J Radiat Biol. 1999 Jan;75(1):91-100.
[MEDLINE record in process]
PMID: 9972795; UI: 99137080.
Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.
Drugs. 1999 Jan;57(1):9-17.
[MEDLINE record in process]
PMID: 9951948; UI: 99135419.
Influence of pulse angle variations on stimulated echo acquisition mode proton nuclear magnetic resonance spectra of AB spin systems: theory and experiments with citrate.
MAGMA. 1998 Dec;7(2):88-94.
[MEDLINE record in process]
PMID: 9951769; UI: 99135240.
Prostate cancer in African-American men.
N C Med J. 1999 Jan-Feb;60(1):10-2.
No abstract available.
[MEDLINE record in process]
PMID: 9951280; UI: 99136431.
A long follow-up on prostate specific antigen density and prostate biopsy.
Arch Esp Urol. 1998 Dec;51(10):1050-3.
[MEDLINE record in process]
PMID: 9951132; UI: 99136283.